findmyKOL

Viranuj Sueblinvong, MD

Basic profile

Emory University

ORCID↗NPI↗
✓ Full record
RegionAtlanta, GA · SoutheastSpecialtyPulmonary DiseaseFocusRespiratory
Active KOLEmergingfindmyKOL type: RegionalLatest publication2026Online presenceNot yet checkedPayments2021 onwardNIH funding2012–2026

Viranuj Sueblinvong is a Respiratory physician affiliated with Emory University. OpenAlex indexes 73 publications with 1,664 citations (h-index 18).

Overview

Scholarship

indexed output and impact (OpenAlex)
View publications ↓
73publications

Distinct works indexed by OpenAlex, matched via ORCID.

1,664citations

Total citations across indexed works.

18h-index

Hirsch index, productivity × impact (OpenAlex).

Clinical & industry

trials, payments and federal funding
1companies · 2021 onward

Companies reporting payments to CMS. Facts, not judgments.

View payments ↓
4NIH grants · 2012–2026

Federally funded research awards.

View funding ↓

Contact

The practice address and phone this provider lists in the federal NPPES (CMS) registry.

Practice address

1525 Clifton Rd NE
4th Floor
Atlanta, GA 303224200

Telephone

404-778-2700

Registry record last updated 11 Sept 2015.

View the NPPES registry record

Industry payments

1 company reported payments to CMS in program years 2021 onward. These are public disclosures, not judgments. The latest:

View the CMS Open Payments record ↗

Payment records matched to this physician's NPI in CMS Open Payments, program years 2021 onward.

Medicare prescribing footprint (2024)

The drugs this prescriber writes for Medicare patients, grouped by drug class and therapeutic area. Every percentage is a share of their total prescribing, so you can see what they prescribe most. These are proportions, not patient counts or dollar amounts. No condition is inferred: the claims record what was prescribed, never why.

  • Respiratory

    58.9%
    Other respiratory system products32.2%
    Trikafta100%
    Part D≥20 patients
    Corticosteroid11.6%
    Symbicort51%Fluticasone Propionate49%
    Part D<11 patients

    + 3 more classes in this area

  • Metabolism & gastrointestinal

    24%
    Antidiarrheal microorganisms13.9%
    Creon52%Zenpep48%
    Part D<11 patients
    Proton pump inhibitor10.1%
    Omeprazole51%Pantoprazole Sodium49%
    Part D<11 patients
  • Anti-infectives

    13.9%
    Macrolide Antimicrobial10.9%
    Azithromycin100%
    Part D≥11 patients
    Polymyxin-class Antibacterial3%
    Colistimethate100%
    Part D<11 patients
Where care is delivered (Part B)91.9% facility · 8.1% office

Drug classes come from the WHO ATC and U.S. National Library of Medicine (RxClass) classifications; prescribing counts come from the CMS Medicare Part D Prescribers file. Each drug is counted once, under its primary class. Medicare fee-for-service only, so no Medicare Advantage, commercial, or pediatric prescribing is included. CMS publishes this data about 17 months after the fact.

NIH funding

4 NIH research awards on record, funded 2012–2026 per NIH RePORTER. The latest:

Awards in the NIH RePORTER records where a principal investigator name matches this physician at an organization in their practice state. Latest award years shown; each row links to the project record on RePORTER.

Publications

Matched to this physician's OpenAlex author record; most-cited works shown first.

Similar KOLs

Other experts from the same institution or the same specialty.

A basic profile from our physician directory: identity and practice contact from the federal NPPES registry, research from OpenAlex, trials from ClinicalTrials.gov, payments from CMS Open Payments, shown itemized where we have matched records, as a count where we only have a total. This person hasn't been through our full identity-adjudication pipeline yet, so funding, congress activity and public presence aren't shown. Absence of a section means “not yet looked,” never “none found.”